Affiliation:
1. University of Cape Coast / Cape Coast Teaching Hospital
2. University of Ghana / Korle-Bu Teaching Hospital
3. Komfo-Anokye Teaching Hospital
4. Kwame Nkrumah University of Science and Technology
5. Pathologists Without Borders Ltd
6. University for Development Studies / Tamale Teaching Hospital
Abstract
Abstract
Introduction:
Due to the absence of a national screening and vaccination program, the burden of cervical cancer in Ghana is staggering. Geographical variations in high-risk Human Papilloma Virus (hrHPV) incidence and type have been documented and should be considered during vaccine improvement and screening, especially in Low Middle-Income Countries (LMICs). We determined the types of hrHPV associated with cervical cancer and compared this to histopathological characteristics of cervical cancer.
Methods:
Cervical cancers were assessed for histopathological features by two independent pathologists following WHO 2014 and 2022 guidelines for the reporting of cervical Squamous Cell Carcinoma (SCC) and Endocervical Adenocarcinoma (EAC). In addition, the novel Tumour Budding and Nest Size Grade (TBNS) for SCC, SILVA pattern of invasion for EAC and Tumour Infiltrating Lymphocytes (TILs) were assessed. High Risk HPV testing was done using an isothermal, multiplex nucleic acid amplification method from ATILA biosystem (Mountain View California, USA).
Results:
A total of 297 cases were identified for the study with ages ranging from 20 to 95 years. The peak age group for cervical cancer was 46 to 55 years. For those tested, hrHPV positivity rate was 85.4% [ EAC (84.6%) and SCC (85.6%)]. The top five hrHPV serotypes for both histological cancers were 59(40%), 35(32%), 18(30%), 16(15%), and 33(10%) respectively. Approximately, 58.2% of infections were multiple. Single hrHPV infections were mostly caused by 59 (28.9%), and hrHPV 16 (26.3%). TBNS grade for SCC, SILVA pattern of invasion for EAC and TILs did not show any statistically significant relationship with hrHPV, though TBNS grade for SCC and SILVA invasion pattern for EAC mirrored the reported late stage and poor prognosis of cervical cancer in Ghana.
Conclusion:
We affirm reported variations in hrHPV types in cervical cancer in Ghana with hrHPV types such as 59, 35, and 33 playing a more significant role. Variations should guide vaccine improvement and triaging of hrHPV positives. Though multiple infections are more common, some hrHPV types such as hrHPV 16 and 59 are responsible for most single infections that result in cervical cancer. Simple haematoxylin and eosin-based morphological assessments can improve the prognostication of patients with cervical cancer.
Publisher
Research Square Platform LLC
Reference23 articles.
1. Human Papilloma Virus and related diseases report. 2023 Document available on the internet at; https://hpvcentre.net/statistics/reports/GHA.pdf. Last accessed on 1st June 2023.
2. HPV and Cancer - National Cancer Institute [Internet]. [cited 2022 Mar 29]. https://www.cancer.gov/about-cancer/causes-prevention/risk/infectious-agents/hpv-and-cancer.
3. WHO. Global Strategy to Accelerate the Elimination of Cervical Cancer as a Public Health Problem. Updated 1/11/2020. ISBN: 9789240014107 Accessed on 21/07/23 from https://www.who.int/publications-detail-redirect/9789240014107.
4. Options in human papillomavirus (HPV) detection for cervical cancer screening: comparison between full genotyping and a rapid qualitative HPV-DNA assay in Ghana;Obiri-Yeboah D;gynaecol oncol res pract,2017
5. Epidemiology of cervical human papillomavirus (HPV) infection and squamous intraepithelial lesions (SIL) among a cohort of HIV-infected and uninfected Ghanaian women;Obiri-Yeboah D;BMC Cancer,2017